---
title: Serum-based biomarkers associated with lung cancer risk and cause-specific
  mortality in the German randomized Lung Cancer Screening Intervention (LUSI) trial
date: '2024-01-11'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38205209/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240111170708&v=2.18.0
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Serum GDF-15 and IL-6 may be useful indicators for estimating
  risks for LC and competing mortality among long-term smokers participating in LC
  screening, to optimize LC screening ...'
disable_comments: true
---
CONCLUSIONS: Serum GDF-15 and IL-6 may be useful indicators for estimating risks for LC and competing mortality among long-term smokers participating in LC screening, to optimize LC screening ...